14 Worst 52-Week High Stocks to Buy According to Short Sellers
The start of the US Federal Reserve cutting cycle ushers a new era in the investment world after one of the longest bull runs.
Tg Therapeutics Inc. (TGTX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Soleus Capital Guy Levy | 3,645,562 | $64,854,548 | +16% | 5.71% |
| 2. | Deep Track Capital David Kroin | 2,870,131 | $51,059,630 | 1.52% | |
| 3. | Opaleye Management James A. Silverman | 2,280,000 | $40,561,200 | 9.26% | |
| 4. | Marshall Wace LLP Paul Marshall And Ian Wace | 2,051,762 | $36,500,846 | 0.04% | |
| 5. | Citadel Investment Group Ken Griffin | 1,859,792 | $33,085,699 | -1% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.13 | 100,000 | Officer, Director | 12,073,021 | 2023-08-11 | Filing | |
| $10.64 | 9,000 | Director | 201,848 | 2023-01-06 | Filing | |
| $7.04 | 50,000 | 12,878,185 | 2019-06-26 | Filing | ||
| $6.53 | 114,855 | Large Shareholder | 5,114,855 | 2015-02-17 | Filing | |
| $3.43 | 10,000 | Large Shareholder, Officer, Director | 7,839,471 | 2013-12-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $16.87 | 16,348 | Director | 105,195 | 2024-06-20 | Filing | |
| $16.39 | 9,585 | Director | 99,293 | 2024-06-17 | Filing | |
| $15.94 | 5,000 | Director | 108,878 | 2024-03-13 | Filing | |
| $15.97 | 22,000 | Director | 215,229 | 2024-03-12 | Filing | |
| $19.03 | 17,500 | Director | 237,229 | 2024-01-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 13,670,944 | $233,499,723 | 0% | |
| 2. | 10,768,163 | $183,920,222 | 0% | |
| 3. | 8,253,573 | $140,971,027 | 0% | |
| 4. | 3,385,245 | $57,819,985 | 0.06% | |
| 5. | 3,139,764 | $53,627,169 | 0.01% |
News See All
TG Therapeutics Inc (NASDAQ:TGTX) A Bull Case Theory
We came across a bullish thesis on TG Therapeutics Inc (TGTX) on ValueInvestorsClub by Bohr. In this article we will summarize the bulls' thesis on TGTX.
TG Therapeutics, Inc. (NASDAQ:TGTX) Q2 2024 Earnings Call Transcript
Operator: Greetings. Welcome to TG Therapeutics’ Conference Second Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode.
TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the TG Therapeutics Conference Call and Webcast. At this time all participants are in a listen-only mode.
13 Best Biotech Stocks To Buy Under $20
In this article, we're going to take a look at 13 best biotech stocks to buy under $20.
TG Therapeutics, Inc. (NASDAQ:TGTX) Q4 2023 Earnings Call Transcript
TG Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.12. TG Therapeutics, Inc.
5 Best Growth Stocks Under $25
Boston, Massachusetts-based Flywire Corporation (NASDAQ:FLYW) is making a case as one of the best growth stocks to buy under $25 heading into 2024, going by its solid growth metrics.
11 Most Promising Biotech Stocks to Buy According to Analysts
In this article, we will take a look at the 11 most promising biotech stocks to buy according to analysts.
TG Therapeutics, Inc. (NASDAQ:TGTX) Q3 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the TG Therapeutics Third Quarter Earnings Update Call. [Operator Instructions] As a reminder, this conference is being recorded.
13 Stocks to Buy with Exponential Growth
Optimism was prevailing in the US stock market on October 11 as investors were hopeful that the Federal Reserve won’t take a hawkish stance for the rest of the year amid rising bond yields that are ...
Billionaire Hedge Funds
